Copyright Reports & Markets. All rights reserved.

Global Hib Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hib Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Hib Vaccine
    • 1.3.3 Multiple Seedlings
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hib Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global Hib Vaccine Market Size & Forecast
    • 1.5.1 Global Hib Vaccine Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Hib Vaccine Sales Quantity (2021-2032)
    • 1.5.3 Global Hib Vaccine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bharat Biotech
    • 2.1.1 Bharat Biotech Details
    • 2.1.2 Bharat Biotech Major Business
    • 2.1.3 Bharat Biotech Hib Vaccine Product and Services
    • 2.1.4 Bharat Biotech Hib Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bharat Biotech Recent Developments/Updates
  • 2.2 Glaxosmithkline
    • 2.2.1 Glaxosmithkline Details
    • 2.2.2 Glaxosmithkline Major Business
    • 2.2.3 Glaxosmithkline Hib Vaccine Product and Services
    • 2.2.4 Glaxosmithkline Hib Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Glaxosmithkline Recent Developments/Updates
  • 2.3 Kangtai Bio
    • 2.3.1 Kangtai Bio Details
    • 2.3.2 Kangtai Bio Major Business
    • 2.3.3 Kangtai Bio Hib Vaccine Product and Services
    • 2.3.4 Kangtai Bio Hib Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Kangtai Bio Recent Developments/Updates
  • 2.4 Lanzhou Institute
    • 2.4.1 Lanzhou Institute Details
    • 2.4.2 Lanzhou Institute Major Business
    • 2.4.3 Lanzhou Institute Hib Vaccine Product and Services
    • 2.4.4 Lanzhou Institute Hib Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Lanzhou Institute Recent Developments/Updates
  • 2.5 Olin Bio
    • 2.5.1 Olin Bio Details
    • 2.5.2 Olin Bio Major Business
    • 2.5.3 Olin Bio Hib Vaccine Product and Services
    • 2.5.4 Olin Bio Hib Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Olin Bio Recent Developments/Updates
  • 2.6 Sanofi Pasteur
    • 2.6.1 Sanofi Pasteur Details
    • 2.6.2 Sanofi Pasteur Major Business
    • 2.6.3 Sanofi Pasteur Hib Vaccine Product and Services
    • 2.6.4 Sanofi Pasteur Hib Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sanofi Pasteur Recent Developments/Updates
  • 2.7 Watson Bio
    • 2.7.1 Watson Bio Details
    • 2.7.2 Watson Bio Major Business
    • 2.7.3 Watson Bio Hib Vaccine Product and Services
    • 2.7.4 Watson Bio Hib Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Watson Bio Recent Developments/Updates
  • 2.8 Zhifei Bio
    • 2.8.1 Zhifei Bio Details
    • 2.8.2 Zhifei Bio Major Business
    • 2.8.3 Zhifei Bio Hib Vaccine Product and Services
    • 2.8.4 Zhifei Bio Hib Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Zhifei Bio Recent Developments/Updates

3 Competitive Environment: Hib Vaccine by Manufacturer

  • 3.1 Global Hib Vaccine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Hib Vaccine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Hib Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Hib Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Hib Vaccine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Hib Vaccine Manufacturer Market Share in 2025
  • 3.5 Hib Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Hib Vaccine Market: Region Footprint
    • 3.5.2 Hib Vaccine Market: Company Product Type Footprint
    • 3.5.3 Hib Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hib Vaccine Market Size by Region
    • 4.1.1 Global Hib Vaccine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Hib Vaccine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Hib Vaccine Average Price by Region (2021-2032)
  • 4.2 North America Hib Vaccine Consumption Value (2021-2032)
  • 4.3 Europe Hib Vaccine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Hib Vaccine Consumption Value (2021-2032)
  • 4.5 South America Hib Vaccine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Hib Vaccine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Hib Vaccine Sales Quantity by Type (2021-2032)
  • 5.2 Global Hib Vaccine Consumption Value by Type (2021-2032)
  • 5.3 Global Hib Vaccine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Hib Vaccine Sales Quantity by Application (2021-2032)
  • 6.2 Global Hib Vaccine Consumption Value by Application (2021-2032)
  • 6.3 Global Hib Vaccine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Hib Vaccine Sales Quantity by Type (2021-2032)
  • 7.2 North America Hib Vaccine Sales Quantity by Application (2021-2032)
  • 7.3 North America Hib Vaccine Market Size by Country
    • 7.3.1 North America Hib Vaccine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Hib Vaccine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Hib Vaccine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Hib Vaccine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Hib Vaccine Market Size by Country
    • 8.3.1 Europe Hib Vaccine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Hib Vaccine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hib Vaccine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Hib Vaccine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Hib Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Hib Vaccine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Hib Vaccine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Hib Vaccine Sales Quantity by Type (2021-2032)
  • 10.2 South America Hib Vaccine Sales Quantity by Application (2021-2032)
  • 10.3 South America Hib Vaccine Market Size by Country
    • 10.3.1 South America Hib Vaccine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Hib Vaccine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hib Vaccine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Hib Vaccine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Hib Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Hib Vaccine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Hib Vaccine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Hib Vaccine Market Drivers
  • 12.2 Hib Vaccine Market Restraints
  • 12.3 Hib Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hib Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hib Vaccine
  • 13.3 Hib Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hib Vaccine Typical Distributors
  • 14.3 Hib Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hib Vaccine market size was valued at US$ 1395 million in 2025 and is forecast to a readjusted size of US$ 2068 million by 2032 with a CAGR of 5.9% during review period.
    Hib vaccine is a vaccine to prevent invasive diseases caused by Hib, such as meningitis, pneumonia, epiglottitis, sepsis, cellulitis, pericarditis, myelitis, etc.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Hib Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hib Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hib Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hib Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hib Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hib Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hib Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bharat Biotech, Glaxosmithkline, Kangtai Bio, Lanzhou Institute, Olin Bio, Sanofi Pasteur, Watson Bio, Zhifei Bio, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hib Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Hib Vaccine
    Multiple Seedlings
    Market segment by Application
    Hospital
    Clinic
    Major players covered
    Bharat Biotech
    Glaxosmithkline
    Kangtai Bio
    Lanzhou Institute
    Olin Bio
    Sanofi Pasteur
    Watson Bio
    Zhifei Bio
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hib Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hib Vaccine, with price, sales quantity, revenue, and global market share of Hib Vaccine from 2021 to 2026.
    Chapter 3, the Hib Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hib Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Hib Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hib Vaccine.
    Chapter 14 and 15, to describe Hib Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now